Design Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
89
Total reported value, excl. options
$84.0M
Manager Report Date Value ($000) Shares